Showing 2141-2150 of 3763 results for "".
Setting Things Right
https://practicaldermatology.com/issues/supplements/setting-things-right/23412/Understanding the Role of Balneotherapy in Treating Moderate to Severe Atopic DermatitisRecent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-42/23844/Recent Developments
https://practicaldermatology.com/columns/recent-developments/the-game-of-drones/23021/Therapeutic Advances in the Topical Management of Acne
https://practicaldermatology.com/issues/supplements/therapeutic-advances-in-the-topical-management-of-acne/21618/New in My Practice: Rx/New Products
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/new-in-my-practice-rxnew-products/23522/Dear New Resident; CSF Grants Available
https://practicaldermatology.com/youngmd-connect/resident-resource-center/dear-new-resident-csf-grants-available/20458/Facing Challenges: Adapting Practice in the Face of COVID-19
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/facing-challenges-adapting-practice-in-the-face-of-covid-19/23266/CSF Faculty share experiences and tips for practicing in the “new normal.”Comorbidities in Hidradenitis Suppurativa
https://practicaldermatology.com/issues/march-2025/comorbidities-in-hidradenitis-suppurativa/33164/Hidradenitis suppurativa (HS) is a chronic, recurrent inflammatory skin disease characterized by inflamed abscesses, nodules forming tunnels that can lead to scarring in intertriginous areas.An Update on the Use of Minocycline for the Treatment of Acne
https://practicaldermatology.com/columns/clinical-focus-1/an-update-on-the-use-of-minocycline-for-the-treatment-of-acne/23201/Advances in formulation technology have led to the development of a stable topical minocycline that recently received FDA approval. Here’s what you should know.Molluscum: Challenges and a Promising Solution
https://practicaldermatology.com/topics/rare-disease/molluscum-challenges-and-a-promising-solution/23532/Molluscum is under-diagnosed and under-treated in the US, but a new treatment could change that.